Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Malignancies × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 299 Carcinoma, Non-Small-Cell Lung 223 Ovarian Neoplasms 153 Lung Neoplasms 111 Neoplasms 80 Fallopian Tube Neoplasms 65 Carcinoma, Ovarian Epithelial 58 Neoplasm Metastasis 53 Esophageal Neoplasms 53 Stomach Neoplasms 46 Head and Neck Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 38 Triple Negative Breast Neoplasms 34 Endometrial Neoplasms 28 Adenocarcinoma of Lung 27 Urinary Bladder Neoplasms 26 Unspecified Adult Solid Tumor, Protocol Specific 23 Esophageal Squamous Cell Carcinoma 23 Melanoma 21 Carcinoma 21 Breast Neoplasms, Male 21 Prostatic Neoplasms 20 Uterine Cervical Neoplasms 19 Recurrence 19 Adenocarcinoma Of Esophagus 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Brenner Tumor 16 Adenocarcinoma, Bronchiolo-Alveolar 16 Small Cell Lung Carcinoma 15 Peritoneal Neoplasms 14

Interventions

ixabepilone 1 ST 1481 1 Paclitaxel 1 Fulvestrant 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02640755 2019-04-22

14C

AstraZeneca

Phase 1 Completed

4 enrolled 34 charts

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡